Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance

Cited by (919)

Items 201–300 of 919

  1. Chitinase 3 Like-1: An Emerging Molecule Involved in Diabetes and Diabetic Complications
    Michelino Di Rosa, Lucia Malaguarnera · 2016 · Pathobiology
  2. Bacterial Peptidoglycan Stimulates Adipocyte Lipolysis via NOD1
    Wendy Chi, Dyda Dao, Trevor C. Lau, Brandyn D. Henriksbo, Joseph F. Cavallari, Kevin P. Foley, Jonathan D. Schertzer · 2014 · PLoS ONE
  3. Lipid-mediated muscle insulin resistance: different fat, different pathways?
    Ritter, Olesja, Jelenik, Tomas, Roden, Michael · 2015 · Journal of Molecular Medicine
  4. Bacterial endotoxin and non‐alcoholic fatty liver disease in the general population: a prospective cohort study
    Vincent Wai‐Sun Wong, Grace Lai‐Hung Wong, Hoi–Yun Chan, D. K.‐W. Yeung, R. S.‐M. Chan, A. M.‐L. Chim, C. K.‐M. Chan, Y.‐K. Tse, J. Woo, W. C.‐W. Chu et al. · 2015 · Alimentary Pharmacology & Therapeutics
  5. Fetuin‐A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects
    Motoya Sato, Yoshihiro Kamada, Yuri Takeda, Sachiho Kida, Yuka Ohara, Hironobu Fujii, Maaya Akita, Kayo Mizutani, Yuichi Yoshida, Makoto Yamada et al. · 2014 · Liver International
  6. The Impact of Adipose Tissue on Insulin Resistance in Acromegaly
    Nicoleta Cristina Olarescu, Jens Bollerslev · 2016 · Trends in Endocrinology and Metabolism
  7. Implication of hepatokines in metabolic disorders and cardiovascular diseases
    Jung, Tae Woo, Yoo, Hye Jin, Choi, Kyung Mook · 2016 · BBA Clinical
  8. Hepatic Macrophage as a Key Player in Fatty Liver Disease
    Liyun Xu, Wen Liu, Fuxiang Bai, Yong Xu, Xiaohong Liang, Chunhong Ma, Lifen Gao · 2021 · Frontiers in Immunology
  9. MECHANISMS IN ENDOCRINOLOGY: Metabolic and inflammatory pathways on the pathogenesis of type 2 diabetes
    Andressa Coope, Adriana Souza Torsoni, Licio Augusto Velloso · 2016 · European Journal of Endocrinology
  10. Unraveling the Effects of PPARβ/δ on Insulin Resistance and Cardiovascular Disease
    Manuel Vázquez‐Carrera · 2016 · Trends in Endocrinology and Metabolism
  11. Pattern recognition receptor‐mediated inflammation in diabetic vascular complications
    Wang, Xu, Antony, Victor, Wang, Yi, Wu, Gaojun, Liang, Guang · 2020 · Medicinal Research Reviews
  12. Macrophages: The Potent Immunoregulatory Innate Immune Cells
    Vijay Kumar · 2019 · IntechOpen eBooks
  13. Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease
    Steven K. Malin, Anny Mulya, Ciarán E. Fealy, Jacob M. Haus, Mangesh R. Pagadala, Amanda R. Scelsi, Hazel Huang, Chris A. Flask, Arthur J. McCullough, John P. Kirwan · 2013 · Journal of Applied Physiology
  14. Increased Fetuin-A Concentrations in Impaired Glucose Tolerance with or without Nonalcoholic Fatty Liver Disease, But Not Impaired Fasting Glucose
    Horng‐Yih Ou, Yi‐Ching Yang, Hung‐Tsung Wu, Jin‐Shang Wu, Feng‐Hwa Lu, Chih‐Jen Chang · 2012 · The Journal of Clinical Endocrinology & Metabolism
  15. Proinflammatory and Antiinflammatory Attributes of Fetu Iν-A: A Novel Hepatokine Modulating Cardiovascular and Glycemic Outcomes in Metabolic Syndrome
    Satinath Mukhopadhyay, Samim Ali Mondal, Manoj Kumar, Deep Dutta · 2014 · Endocrine Practice
  16. Regulation of the novel adipokines/ hepatokines fetuin A and fetuin B in gestational diabetes mellitus
    Susan Kralisch, Annett Hoffmann, Ulrike Lössner, Jürgen Kratzsch, Matthias Blüher, Michael Stümvoll, Mathias Faßhauer, Thomas Ebert · 2016 · Metabolism
  17. Testicular germ cell apoptosis and sperm defects in mice upon long‐term high fat diet feeding
    Songita Ghosh, Sutapa Mukherjee · 2018 · Journal of Cellular Physiology
  18. Increased adipose tissue secretion of Fetuin-A, lipopolysaccharide-binding protein and high-mobility group box protein 1 in metabolic syndrome
    Ishwarlal Jialal, Sridevi Devaraj, Ahmed Bettaieb, Fawaz G. Haj, BEVERLEY A. ADAMS-HUET · 2015 · Atherosclerosis
  19. Systems Biology Approach Reveals Genome to Phenome Correlation in Type 2 Diabetes
    Priyanka Jain, Saurabh Vig, Malabika Datta, Dinesh Jindel, Ashok Kumar Mathur, Sandeep Kumar Mathur, Abhay Sharma · 2013 · PLoS ONE
  20. Plant Extracts and Reactive Oxygen Species as Two Counteracting Agents with Anti- and Pro-Obesity Properties
    Hanna Zielińska‐Bliźniewska, Przemysław Sitarek, Anna Merecz-Sadowska, Katarzyna Malinowska, Karolina Zajdel, Marta R. Jabłońska, Tomasz Śliwiński, Radosław Zajdel · 2019 · International Journal of Molecular Sciences
  21. Mitochondria: sensors and mediators of innate immune receptor signaling
    Suzanne M. Cloonan, Augustine M.K. Choi · 2013 · Current Opinion in Microbiology
  22. Toll-like receptor 2/4 links to free fatty acid-induced inflammation and β-cell dysfunction
    Jiajing Yin, Yongde Peng, Jingcheng Wu, Yufan Wang, Lili Yao · 2013 · Journal of Leukocyte Biology
  23. Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle
    Tae Woo Jung, Yoon Hee Chung, Hyoung‐Chun Kim, A.M. Abd El‐Aty, Ji Hoon Jeong · 2017 · Molecular and Cellular Endocrinology
  24. Fetuin-A levels and risk of type 2 diabetes mellitus: a systematic review and meta-analysis
    Vivian Yawei Guo, Bing Cao, Chunyan C. Cai, Kenneth K.Y. Cheng, Bernard M.Y. Cheung · 2017 · Acta Diabetologica
  25. The effect of adipocyte–macrophage crosstalk in obesity-related breast cancer
    Ayşe Başak Engin, Atilla Engin, İpek Işık Gönül · 2019 · Journal of Molecular Endocrinology
  26. Targeting danger-associated molecular patterns after myocardial infarction
    Gerardus P. J. van Hout, Fatih Arslan, Gerard Pasterkamp, Imo E. Hoefer · 2015 · Expert Opinion on Therapeutic Targets
  27. Urinary Fetuin-A Is a Novel Marker for Diabetic Nephropathy in Type 2 Diabetes Identified by Lectin Microarray
    Kentaro Inoue, Jun Wada, Jun Eguchi, Atsuko Nakatsuka, Sanae Teshigawara, Kazutoshi Murakami, Daisuke Ogawa, Takahiro Terami, Akihiro Katayama, Atsuhito Tone et al. · 2013 · PLoS ONE
  28. A Novel Ligand of Toll-like Receptor 4 From the Sheath of Wuchereria bancrofti Microfilaria Induces Proinflammatory Response in Macrophages
    Suprabhat Mukherjee, Sandip Mukherjee, Tushar Kanti Maiti, Samir Bhattacharya, Santi P. Sinha Babu · 2017 · The Journal of Infectious Diseases
  29. Impact of Fetuin-A (AHSG) on Tumor Progression and Type 2 Diabetes
    Josiah Ochieng, Gladys N. Nangami, Amos M. Sakwe, Cierra Moye, Joel Alvarez, Diva S. Whalen, Portia L. Thomas, Philip Edward Lammers · 2018 · International Journal of Molecular Sciences
  30. Fetuin A promotes lipotoxicity in β cells through the TLR4 signaling pathway and the role of pioglitazone in anti-lipotoxicity
    Shen, Ximei, Yang, Liyong, Yan, Sunjie, Zheng, Huanhuan, Liang, Liyu, Cai, Xiuhui, Liao, Meng · 2015 · Molecular and Cellular Endocrinology
  31. Interaction between plasma fetuin‐A and free fatty acids predicts changes in insulin sensitivity in response to long‐term exercise
    Sindre Lee-Ødegård, Frode Norheim, Hanne Løvdal Gulseth, Torgrim Mikal Langleite, Kristoffer Jensen Kolnes, Daniel Steensen Tangen, Hans Kristian Stadheim, Gregor D. Gilfillan, Torgeir Holen, Kåre I. Birkeland et al. · 2017 · Physiological Reports
  32. Skeletal muscle and MASLD: Mechanistic and clinical insights
    Thomas Marjot, Matthew James Armstrong, Jonathan G. Stine · 2025 · Hepatology Communications
  33. Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis
    Xin Yi Xu, Linlin Lu, Quanyong Dong, Xiaolin Li, Nannan Zhang, Yongning Xin, Shiying Xuan · 2015 · Lipids in Health and Disease
  34. The Impact of Organokines on Insulin Resistance, Inflammation, and Atherosclerosis
    Kyung Mook Choi · 2016 · Endocrinology and Metabolism
  35. Clinical implications of fetuin-A
    Peter Jirak, Lars Stechemesser, Elena Morè, Michael Franzen, Albert Topf, Moritz Mirna, Vera Paar, Rudin Pistulli, Daniel Kretzschmar, Bernhard Wernly et al. · 2019 · Advances in clinical chemistry
  36. Green Tea Polyphenol Epigallocatechin-3-gallate Suppresses Toll-like Receptor 4 Expression via Up-regulation of E3 Ubiquitin-protein Ligase RNF216
    Motofumi Kumazoe, Yuki Nakamura, Mai Yamashita, Takashi Suzuki, Kanako Takamatsu, Yuhui Huang, Jae‐Hoon Bae, Shuya Yamashita, Motoki Murata, Shuhei Yamada et al. · 2017 · Journal of Biological Chemistry
  37. Obesity, diabetes, and inflammation: Pathophysiology and clinical implications
    Marc Yves Donath, Daniel J. Drucker · 2025 · Immunity
  38. Toll-Like Receptor, Lipotoxicity and Chronic inflammation: The Pathological Link Between Obesity and Cardiometabolic Disease
    Kosei Eguchi, Ichiro Manabe · 2014 · Journal of Atherosclerosis and Thrombosis
  39. Fetuin-A influences vascular cell growth and production of proinflammatory and angiogenic proteins by human perivascular fat cells
    Dorothea I. Siegel-Axel, Susanne Ullrich, Norbert Stefan, Kilian Rittig, Felicia Gerst, Christian Klingler, Ulrike Schmidt, Birgit Schreiner, Elko Randrianarisoa, Hans‐Eberhard Schaller et al. · 2014 · Diabetologia
  40. LECT2 as a hepatokine links liver steatosis to inflammation via activating tissue macrophages in NASH
    Noboru Takata, Kiyo‐aki Ishii, Hiroaki Takayama, Mayumi Nagashimada, Kyoko Kamoshita, Takeo Tanaka, Akihiro Kikuchi, Yumie Takeshita, Yukako Matsumoto, Tsuguhito Ota et al. · 2021 · Scientific Reports
  41. Novel strategies for glycaemic control and preventing diabetic complications applying the clustering-based classification of adult-onset diabetes mellitus: A perspective
    Hayato Tanabe, Hiroaki Masuzaki, Michio Shimabukuro · 2021 · Diabetes Research and Clinical Practice
  42. MicroRNA-122-5p Inhibition Improves Inflammation and Oxidative Stress Damage in Dietary-Induced Non-alcoholic Fatty Liver Disease Through Targeting FOXO3
    Yiyi Hu, Xuetao Peng, Guoping Du, Zhiqiao Zhang, Yingji Zhai, Xingbo Xiong, Xiaoliang Luo · 2022 · Frontiers in Physiology
  43. Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis
    Violaine Harris, Nicola R. Donelan, Qi Jiang Yan, Kristi Clark, Amir Touray, Mustapha Rammal, Saud Ahmed Sadiq · 2013 · Multiple Sclerosis Journal
  44. The Spleen: A Hub Connecting Nervous and Immune Systems in Cardiovascular and Metabolic Diseases
    Andrea Lori, Marialuisa Perrotta, Giuseppe Lembo, Daniela Carnevale · 2017 · International Journal of Molecular Sciences
  45. Toll-like receptor 4 (TLR4) deficient mice are protected from adipose tissue inflammation in aging
    Amiya Kumar Ghosh, Martin O’Brien, Theresa Mau, Raymond L. Yung · 2017 · Aging
  46. Palmitic acid triggers inflammatory responses in N42 cultured hypothalamic cells partially via ceramide synthesis but not via TLR4
    Domenico Sergi, Amanda C. Morris, DARCY E. KAHN, Fiona Hamilton McLean, Elizabeth A. Hay, Phil Kubitz, Alasdair MacKenzie, Maria‐Grazia Martinoli, Janice E. Drew, Lynda M. Williams · 2018 · Nutritional Neuroscience
  47. Hepatic Small Ubiquitin‐Related Modifier (SUMO)–Specific Protease 2 Controls Systemic Metabolism Through SUMOylation‐Dependent Regulation of Liver–Adipose Tissue Crosstalk
    Yang Liu, Xin Dou, Weiyu Zhou, Meng Ding, Ling Liu, Ruo‐qi Du, Liang Guo, Shuwen Qian, Yan Tang, Qi‐qi Yang et al. · 2021 · Hepatology
  48. Regulatory mechanisms of macrophage polarization in adipose tissue
    Dun Pan, Li Guo, Chunlin Jiang, Jinfeng Hu, Xiangming Hu · 2023 · Frontiers in Immunology
  49. Insulin infusion suppresses while glucose infusion induces Toll-like receptors and high-mobility group-B1 protein expression in mononuclear cells of type 1 diabetes patients
    Paresh Dandona, Husam Ghanim, Kelly Green, Chang Ling Sia, Sanaa Abuaysheh, Nitesh D Kuhadiya, Manav Batra, Sandeep Dhindsa, Ajay Chaudhuri · 2013 · American Journal of Physiology-Endocrinology and Metabolism
  50. Helicobacter pylori and Risk of Nonalcoholic Fatty Liver Disease
    Karn Wijarnpreecha, Charat Thongprayoon, Panadeekarn Panjawatanan, Wuttiporn Manatsathit, Veeravich Jaruvongvanich, Patompong Ungprasert · 2017 · Journal of Clinical Gastroenterology
  51. Palmitate Conditions Macrophages for Enhanced Responses toward Inflammatory Stimuli via JNK Activation
    Marta Riera-Borrull, Víctor D. Cuevas, Bárbara Alonso, Miguel A. Vega, Jorge Joven, Elena Izquierdo, Angel Luis Corbí · 2017 · The Journal of Immunology
  52. Negatively regulating TLR4/NF-κB signaling via PPARα in endotoxin-induced uveitis
    Wei Shen, Yang Gao, Boyu Lu, Qingjiong Zhang, Yang Hu, Ying Chen · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  53. Inflammasomes in pancreatic physiology and disease
    Rafaz Hoque, Wajahat Zafar Mehal · 2015 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  54. Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients
    Alişan Kahraman, Jan‐Peter Sowa, Martin Schlattjan, Svenja Sydor, Martin Pronadl, Alexander Wree, A Beilfuss, Alpaslan Kılıçarslan, Akif Altınbaş, Lars P. Bechmann et al. · 2013 · Clinical Science
  55. Tissue-Specific Differences in the Development of Insulin Resistance in a Mouse Model for Type 1 Diabetes
    Tomáš Jeleník, Gilles Séquaris, Kirti Kaul, D. Margriet Ouwens, Esther Phielix, Jörg Kotzka, Birgit Knebel, Jürgen Weiß, Anna Lena Reinbeck, Linda Janke et al. · 2014 · Diabetes
  56. Bartonella quintana lipopolysaccharide (LPS): structure and characteristics of a potent TLR4 antagonist for in-vitro and in-vivo applications
    Gosia Malgorzata-Miller, Lena Heinbockel, Klaus Brandenburg, Jos W. M. van der Meer, Mihai Gheorghe Netea, Leo A. B. Joosten · 2016 · Scientific Reports
  57. Lipid bilayer stress in obesity-linked inflammatory and metabolic disorders
    Marco A. Gianfrancesco, Nicolas Paquot, Jacques G. Piette, Sylvie Legrand-Poels · 2018 · Biochemical Pharmacology
  58. Bone marrow lympho-myeloid malfunction in obesity requires precursor cell-autonomous TLR4
    Ailing Liu, Minhui Chen, Rashmi J. Kumar, Maja Stefanović-Račić, Robert Martin O'Doherty, Ying Ding, Willi Jahnen‐Dechent, Lisa Borghesi · 2018 · Nature Communications
  59. Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease
    Xiaoyan Li, Hua Wang · 2020 · Cell & Bioscience
  60. Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms
    Takahashi, Hirokazu, Kotani, Kazuhiko, Tanaka, Kenichi, Egucih, Yuichiro, Anzai, Keizo · 2018 · Frontiers in Endocrinology
  61. Potential beneficial effect of some adipokines positively correlated with the adipose tissue content on the cardiovascular system
    Magdalena Sawicka, Joanna Janowska, Jerzy Tadeusz Chudek · 2016 · International Journal of Cardiology
  62. Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease
    Vittoria Zambon Azevedo, Cristina Alina Silaghi, Thomas Maurel, Horațiu Silaghi, Vlad Ratziu, Raluca Pais · 2022 · Frontiers in Nutrition
  63. Saturated fatty acid-enriched small extracellular vesicles mediate a crosstalk inducing liver inflammation and hepatocyte insulin resistance
    Irma García‐Martinez, Rosa Alén, Laura Pereira, Adrián Povo‐Retana, Alma M. Astudillo, Ana B. Hitos, Isabel Gómez‐Hurtado, Eduardo López‐Collazo, Lisardo Boscá, Rubén Francés et al. · 2023 · JHEP Reports
  64. Caspases and inflammasomes in metabolic inflammation
    Alexander M. Skeldon, May Faraj, Maya Saleh · 2014 · Immunology and Cell Biology
  65. Obesity and renal disease: not all fat is created equal and not all obesity is harmful to the kidneys.
    N. Stefan, F. Artunc, N. Heyne, J. Machann, E. Schleicher, H. Häring · 2016 · Nephrology, Dialysis and Transplantation
  66. Metabolic regulation in the immune response to cancer
    Qi Wu, Xin Yu, Juanjuan Li, Shengrong Sun, Yi Tu · 2021 · 癌症:英文版
  67. Role of exercise-induced hepatokines in metabolic disorders
    Ennequin, Gaël, Sirvent, Pascal, Whitham, Martin · 2019 · American Journal of Physiology-Endocrinology and Metabolism
  68. Visceral and subcutaneous adipose tissue express and secrete functional alpha2hsglycoprotein (fetuin a) especially in obesity
    Diego Pérez-Sotelo, Arturo Roca-Rivada, María Larrosa-García, Cecilia Castelao, Iván Baamonde de la Torre, Javier Baltar, Ana Belen Crujeiras, Luisa Maria Seoane, Felipe F. Casanueva, María Pardo · 2016 · Endocrine
  69. Global obesity research trends during 1999 to 2017
    Ning Zhao, Kaixiong Tao, Guobin Wang, Zefeng Xia · 2019 · Medicine
  70. Fetuin-A is a HIF target that safeguards tissue integrity during hypoxic stress
    Stefan Rudloff, Mathilde Janot, Stéphane Rodriguez, Kévin Dessalle, Willi Jahnen‐Dechent, Uyen Huynh‐Do · 2021 · Nature Communications
  71. Novel phenotypes of prediabetes?
    Hans‐Ulrich Häring · 2016 · Diabetologia
  72. Oxidized LDL upregulates macrophage DPP4 expression via TLR4/TRIF/CD36 pathways
    Xiaoquan Rao, Shi Wen Zhao, Zachary Braunstein, Hong Mao, Michael A. Razavi, Lihua Duan, Yingying Wei, Amelia C. Toomey, Sanjay Rajagopalan, Jixin Zhong · 2019 · EBioMedicine
  73. Increasing Dietary Medium-Chain Fatty Acid Ratio Mitigates High-fat Diet-Induced Non-Alcoholic Steatohepatitis by Regulating Autophagy
    Mu‐En Wang, Brijesh Kumar Singh, Meng-Chieh Hsu, Chien Hsiang Huang, Paul M. Yen, Leang‐Shin Wu, De‐Shien Jong, Chih‐Hsien Chiu · 2017 · Scientific Reports
  74. MicroRNA-194 inhibition improves dietary-induced non-alcoholic fatty liver disease in mice through targeting on FXR
    Hezhongrong Nie, Chunli Song, Daming Wang, Shengjin Cui, Tingyu Ren, Zhaopeng Cao, Qing Liu, Zeyan Chen, Xiaoyong Chen, Yiwen Zhou · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  75. Homeostatic and pathogenic roles of GM3 ganglioside molecular species in TLR4 signaling in obesity
    Hirotaka Kanoh, Takahiro Nitta, Shinji Go, Kei‐ichiro Inamori, Lucas J. Veillon, Wataru Nihei, Mayu Fujii, Kazuya Kabayama, Atsushi Shimoyama, Koichi Fukase et al. · 2020 · The EMBO Journal
  76. Effects of fetuin-A with diverse functions and multiple mechanisms on human health
    Mehmet Arif İçer, Hilal Yıldıran · 2020 · Clinical Biochemistry
  77. The Diabetes Risk Phenotype of Young Women With Recent Gestational Diabetes
    Marietta Rottenkolber, Uta Ferrari, Lukas Holland, Stephanie Aertsen, Nora N. Kammer, Holger Hetterich, Marina Fugmann, Friederike Banning, M. Weise, Vanessa Sacco et al. · 2015 · The Journal of Clinical Endocrinology & Metabolism
  78. Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes
    Mia Jüllig, Shelley Yip, Aimin Xu, Greg Smith, Martin Middleditch, Michael Booth, Richard Babor, Grant R. Beban, Rinki Murphy · 2014 · PLoS ONE
  79. Potential role ofHelicobacter pyloriinfection in nonalcoholic fatty liver disease
    Meng Li · 2013 · World Journal of Gastroenterology
  80. β- cell dynamics in type 2 diabetes and in dietary and exercise interventions
    Cheng-an Lv, Yuchen Sun, Zhe Yu Zhang, Zeyad Aboelela, Xinyuan Qiu, Zhuo‐Xian Meng · 2022 · Journal of Molecular Cell Biology
  81. Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers
    Alessandro Mantovani, Amedeo Lonardo, Norbert Stefan, Giovanni Targher · 2024 · Metabolism
  82. Circulating plasma microRNAs dysregulation and metabolic endotoxemia induced by a high-fat high-saturated diet
    Bruna Jardim Quintanilha, Ludmila Rodrigues Pinto Ferreira, Frederico Moraes Ferreira, Edécio Cunha‐Neto, Geni Rodrigues Sampaio, Marcelo Macedo Rogero · 2019 · Clinical Nutrition
  83. Long-term bisphenol A exposure exacerbates diet-induced prediabetes via TLR4-dependent hypothalamic inflammation
    Qinlong Ma, Ping Deng, Min Lin, Lingling Yang, Le Li, Lu Guo, Lei Zhang, Mindi He, Yonghui Lu, Huifeng Pi et al. · 2020 · Journal of Hazardous Materials
  84. Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics
    Maxime S. Heroux, Marla A. Chesnik, Brian D. Halligan, Mona M. Al-Gizawiy, Jennifer Connelly, Wade M. Mueller, Scott D. Rand, Elizabeth J. Cochran, Peter S. LaViolette, Mark Gordon Malkin et al. · 2014 · Physiological Genomics
  85. The association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies
    Farzad Roshanzamir, Maryam Sadat Miraghajani, Mohammad Hossein Rouhani, Marjan Mansourian, Reza Ghiasvand, Sayyed Morteza Safavi · 2017 · Journal of Endocrinological Investigation
  86. Antioxidant bilirubin works in multiple ways to reduce risk for obesity and its health complications
    James J. DiNicolantonio, Mark Frederick McCarty, James Henry O’Keefe · 2018 · Open Heart
  87. Distinct Transcriptional Responses across Tissue-Resident Macrophages to Short-Term and Long-Term Metabolic Challenge
    Urszula Brykczynska, Marco Geigges, Sophia J. Wiedemann, Erez Dror, Marianne Böni‐Schnetzler, Christoph Hess, Marc Yves Donath, Renato Paro · 2020 · Cell Reports
  88. Postulates for validating TLR4 agonists
    Mateja Manček‐Keber, Roman Jerala · 2014 · European Journal of Immunology
  89. Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight
    Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, Giovanni Targher, Amedeo Lonardo · 2016 · International Journal of Molecular Sciences
  90. The Human Colostrum Whey Proteome Is Altered in Gestational Diabetes Mellitus
    Dmitry Grapov, Danielle G. Lemay, Darren Weber, Brett S. Phinney, Ilana R. Azulay Chertok, Deborah S. Gho, J. Bruce German, Jennifer T. Smilowitz · 2014 · Journal of Proteome Research
  91. Hepatic F-Box Protein FBXW7 Maintains Glucose Homeostasis Through Degradation of Fetuin-A
    Jiejie Zhao, Xuelian Xiong, Yao Li, Xing Liu, Tao Wang, Hong Zhang, Yang Jiao, Jingjing Jiang, Huijie Zhang, Qi‐Qun Tang et al. · 2018 · Diabetes
  92. TLR4 triggered complex inflammation in human pancreatic islets
    Wei He, Osmond D. Rebello, Rocco Savino, Rosa Terracciano, Carole Schuster, Béatrice Guardiola, Kathrin Maedler · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  93. The Targeted Impact of Flavones on Obesity-Induced Inflammation and the Potential Synergistic Role in Cancer and the Gut Microbiota
    Meenakshi Sudhakaran, Andrea I. Doseff · 2020 · Molecules
  94. Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
    Tae Hyun Kim, Dong-Gyun Hong, Yoon Mee Yang · 2021 · Biomedicines
  95. Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma: Implications for Lycopene Intervention
    Blanche C. Ip, Xiangdong Wang · 2013 · Nutrients
  96. The expression of genes involved in NF-κB activation in peripheral blood mononuclear cells of patients with gestational diabetes
    Mariusz Kuźmicki, Beata Telejko, Natalia Wawrusiewicz‐Kurylonek, Danuta Lipińska, Justyna Pliszka, Julisz Wilk, Anna Zielińska, Justyna Skibicka, Jacek Szamatowicz, Adam Jacek Kretowski et al. · 2012 · European Journal of Endocrinology
  97. Toll-like Receptor 4 in COVID-19: Friend Or foe?
    Suprabhat Mukherjee · 2022 · Future Virology
  98. On the Immunometabolic Role of NF-κB in Adipocytes
    Michael J. Griffin · 2022 · Immunometabolism
  99. Saturated fatty acid (SFA) status and SFA intake exhibit different relations with serum total cholesterol and lipoprotein cholesterol: a mechanistic explanation centered around lifestyle-induced low-grade inflammation
    Begoña Ruiz-Núñez, Remko S. Kuipers, Martine F. Luxwolda, Deti J. De Graaf, Benjamin B. Breeuwsma, Janneke Dijck-Brouwer, Frits A.J. Muskiet · 2013 · The Journal of Nutritional Biochemistry
  100. Rapid sandwich ELISA-based in vitro diagnostic procedure for the highly-sensitive detection of human fetuin A
    Sandeep Kumar Vashist, E. Marion Schneider, John H. T. Luong · 2014 · Biosensors and Bioelectronics